Literature DB >> 7190239

Juvenile myasthenia gravis.

O C Snead, J W Benton, D Dwyer, B J Morley, G E Kemp, R J Bradley, S J Oh.   

Abstract

We studied 32 children with myasthenia gravis over a period of 12 years. The mean age at onset was 7.7 years. Presentation was ocular in 63% of patients. Another major disease in addition to myasthenia occurred in 44% of patients; a seizure disorder was the most commonly associated disease. Serum IgG antibody to nicotinic acetylcholine receptor was present in 53% of patients and did not correlate with severity of disease or treatment. Medical management was effective in 63%; thymectomy was effective in only 28%. We conclude that myasthenia gravis appears commonly before age 10 and is associated with the risk of some disease other than hyperthyroidism. Serum IgG nicotinic acetylcholine receptor antibody is present less frequently than in normal adults, and vigorous medical management should be attempted before thymectomy.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7190239     DOI: 10.1212/wnl.30.7.732

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  4 in total

Review 1.  Muscular dystrophies.

Authors:  L Specht
Journal:  Indian J Pediatr       Date:  1990 May-Jun       Impact factor: 1.967

2.  Thymectomy in black children with juvenile myasthenia gravis.

Authors:  K Lakhoo; J D Fonseca; J Rodda; M R Davies
Journal:  Pediatr Surg Int       Date:  1997-02       Impact factor: 1.827

3.  Myasthenia gravis.

Authors:  R Anandam
Journal:  Indian J Pediatr       Date:  1989 Mar-Apr       Impact factor: 1.967

4.  Immunosuppressive treatment for juvenile myasthenia gravis.

Authors:  B Badurska; B Ryniewicz; H Strugalska
Journal:  Eur J Pediatr       Date:  1992-03       Impact factor: 3.183

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.